|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1993-9-21
|
|
pubmed:abstractText |
To assess the safety of vaginal recombinant human relaxin in pregnant women treated before the induction of labor and to collect preliminary data on the efficacy of recombinant human relaxin in promoting cervical ripening.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0029-7844
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
328-33
|
|
pubmed:dateRevised |
2009-10-26
|
|
pubmed:meshHeading |
pubmed-meshheading:8355929-Administration, Intravaginal,
pubmed-meshheading:8355929-Adult,
pubmed-meshheading:8355929-Cervix Uteri,
pubmed-meshheading:8355929-Double-Blind Method,
pubmed-meshheading:8355929-Female,
pubmed-meshheading:8355929-Humans,
pubmed-meshheading:8355929-Labor, Induced,
pubmed-meshheading:8355929-Pregnancy,
pubmed-meshheading:8355929-Pregnancy, Prolonged,
pubmed-meshheading:8355929-Recombinant Proteins,
pubmed-meshheading:8355929-Relaxin,
pubmed-meshheading:8355929-Uterine Contraction
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
A randomized, double-blind, placebo-controlled trial of the safety of vaginal recombinant human relaxin for cervical ripening.
|
|
pubmed:affiliation |
Howard Florey Institute, University of Melbourne, Victoria, Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
